Metabolic and Biochemical Effects of Pyrroloquinoline Quinone (PQQ) on Inflammation and Mitochondrial Dysfunction: Potential Health Benefits in Obesity and Future Perspectives
Abstract
:1. Introduction
2. PQQ: Structure and General Characteristics
3. PQQ and Adipose Tissue
4. PQQ and Mitochondrial Dysfunction
5. PQQ and Inflammation
6. PQQ and Skeletal Muscle Health
7. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- The GBD 2015 Obesity Collaborators. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med. 2017, 377, 13–27. [Google Scholar] [CrossRef]
- Lin, X.; Li, H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front. Endocrinol. 2021, 12, 706978. [Google Scholar] [CrossRef] [PubMed]
- de Mello, A.H.; Costa, A.B.; Engel, J.D.G.; Rezin, G.T. Mitochondrial Dysfunction in Obesity. Life Sci. 2018, 192, 26–32. [Google Scholar] [CrossRef]
- Wang, S.; Liu, Y.; Chen, J.; He, Y.; Ma, W.; Liu, X.; Sun, X. Effects of Multi-Organ Crosstalk on the Physiology and Pathology of Adipose Tissue. Front. Endocrinol. 2023, 14, 1198984. [Google Scholar] [CrossRef]
- Ji, Y.; Li, M.; Chang, M.; Liu, R.; Qiu, J.; Wang, K.; Deng, C.; Shen, Y.; Zhu, J.; Wang, W.; et al. Inflammation: Roles in Skeletal Muscle Atrophy. Antioxidants 2022, 11, 1686. [Google Scholar] [CrossRef] [PubMed]
- Zhang, H.; Qi, G.; Wang, K.; Yang, J.; Shen, Y.; Yang, X.; Chen, X.; Yao, X.; Gu, X.; Qi, L.; et al. Oxidative Stress: Roles in Skeletal Muscle Atrophy. Biochem. Pharmacol. 2023, 214, 115664. [Google Scholar] [CrossRef] [PubMed]
- Romanello, V.; Sandri, M. The Connection between the Dynamic Remodeling of the Mitochondrial Network and the Regulation of Muscle Mass. Cell. Mol. Life Sci. 2021, 78, 1305–1328. [Google Scholar] [CrossRef]
- Scicchitano, B.M.; Pelosi, L.; Sica, G.; Musarò, A. The Physiopathologic Role of Oxidative Stress in Skeletal Muscle. Mech. Ageing Dev. 2018, 170, 37–44. [Google Scholar] [CrossRef]
- Mengeste, A.M.; Rustan, A.C.; Lund, J. Skeletal Muscle Energy Metabolism in Obesity. Obesity 2021, 29, 1582–1595. [Google Scholar] [CrossRef]
- Iyengar, N.M.; Gucalp, A.; Dannenberg, A.J.; Hudis, C.A. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. J. Clin. Oncol. 2016, 34, 4270–4276. [Google Scholar] [CrossRef]
- Turck, D.; Bresson, J.; Burlingame, B.; Dean, T.; Fairweather-Tait, S.; Heinonen, M.; Hirsch-Ernst, K.I.; Mangelsdorf, I.; McArdle, H.J.; Naska, A.; et al. Safety of Pyrroloquinoline Quinone Disodium Salt as a Novel Food Pursuant to Regulation (EC) No 258/97. EFSA J. 2017, 15, e05058. [Google Scholar] [CrossRef] [PubMed]
- Jonscher, K.R.; Chowanadisai, W.; Rucker, R.B. Pyrroloquinoline-Quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention. Biomolecules 2021, 11, 1441. [Google Scholar] [CrossRef]
- He, K.; Nukada, H.; Urakami, T.; Murphy, M.P. Antioxidant and Pro-Oxidant Properties of Pyrroloquinoline Quinone (PQQ): Implications for Its Function in Biological Systems. Biochem. Pharmacol. 2003, 65, 67–74. [Google Scholar] [CrossRef] [PubMed]
- Zhang, M.; Zhang, J.; Xiong, Y.; Peng, J.; Wu, X. Pyrroloquinoline Quinone Inhibits Oxidative Stress in Rats with Diabetic Nephropathy. Med. Sci. Monit. 2020, 26, e924372-1. [Google Scholar] [CrossRef]
- Mohamad Ishak, N.S.; Ikemoto, K. Pyrroloquinoline-Quinone to Reduce Fat Accumulation and Ameliorate Obesity Progression. Front. Mol. Biosci. 2023, 10, 1200025. [Google Scholar] [CrossRef] [PubMed]
- Wu, Y.; Zhao, M.; Lin, Z. Pyrroloquinoline Quinone (PQQ) Alleviated Sepsis-Induced Acute Liver Injury, Inflammation, Oxidative Stress and Cell Apoptosis by Downregulating CUL3 Expression. Bioengineered 2021, 12, 2459–2468. [Google Scholar] [CrossRef]
- Singh, A.K.; Pandey, S.K.; Saha, G.; Gattupalli, N.K. Pyrroloquinoline Quinone (PQQ) Producing Escherichia Coli Nissle 1917 (EcN) Alleviates Age Associated Oxidative Stress and Hyperlipidemia, and Improves Mitochondrial Function in Ageing Rats. Exp. Gerontol. 2015, 66, 1–9. [Google Scholar] [CrossRef]
- Devasani, K.; Majumdar, A. Pyrroloquinoline Quinone Attenuates Obesity Associated Low Grade Inflammation. Obes. Med. 2019, 16, 100134. [Google Scholar] [CrossRef]
- Shiojima, Y.; Takahashi, M.; Takahashi, R.; Moriyama, H.; Bagchi, M.; Kanbayashi, I.; Sasaki, T.; Goda, T.; Bagchi, D. Efficacy and Safety of a Novel Dietary Pyrroloquinoline Quinone Disodium Salt on Muscle Strength and Physical Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Study. J. Funct. Foods 2024, 113, 106012. [Google Scholar] [CrossRef]
- Mohamad Ishak, N.S.; Kikuchi, M.; Ikemoto, K. Dietary Pyrroloquinoline Quinone Hinders Aging Progression in Male Mice and D-Galactose-Induced Cells. Front. Aging 2024, 5, 1351860. [Google Scholar] [CrossRef]
- Qiu, J.; Fang, Q.; Xu, T.; Wu, C.; Xu, L.; Wang, L.; Yang, X.; Yu, S.; Zhang, Q.; Ding, F.; et al. Mechanistic Role of Reactive Oxygen Species and Therapeutic Potential of Antioxidants in Denervation- or Fasting-Induced Skeletal Muscle Atrophy. Front. Physiol. 2018, 9, 215. [Google Scholar] [CrossRef] [PubMed]
- Kuo, Y.-T.; Shih, P.-H.; Kao, S.-H.; Yeh, G.-C.; Lee, H.-M. Pyrroloquinoline Quinone Resists Denervation-Induced Skeletal Muscle Atrophy by Activating PGC-1α and Integrating Mitochondrial Electron Transport Chain Complexes. PLoS ONE 2015, 10, e0143600. [Google Scholar] [CrossRef] [PubMed]
- Xu, T.; Yang, X.; Wu, C.; Qiu, J.; Fang, Q.; Wang, L.; Yu, S.; Sun, H. Pyrroloquinoline Quinone Attenuates Cachexia-Induced Muscle Atrophy via Suppression of Reactive Oxygen Species. J. Thorac. Dis. 2018, 10, 2752–2759. [Google Scholar] [CrossRef]
- Hauge, J.G. Glucose Dehydrogenase of Bacterium Anitratum: An Enzyme with a Novel Prosthetic Group. J. Biol. Chem. 1964, 239, 3630–3639. [Google Scholar] [CrossRef] [PubMed]
- Akagawa, M.; Nakano, M.; Ikemoto, K. Recent Progress in Studies on the Health Benefits of Pyrroloquinoline Quinone. Biosci. Biotechnol. Biochem. 2016, 80, 13–22. [Google Scholar] [CrossRef] [PubMed]
- Kumazawa, T.; Sato, K.; Seno, H.; Ishii, A.; Suzuki, O. Levels of Pyrroloquinoline Quinone in Various Foods. Biochem. J. 1995, 307, 331–333. [Google Scholar] [CrossRef]
- Rucker, R.; Chowanadisai, W.; Nakano, M. Potential Physiological Importance of Pyrroloquinoline Quinone. Altern. Med. Rev. 2009, 14, 268–277. [Google Scholar]
- Harris, C.B.; Chowanadisai, W.; Mishchuk, D.O.; Satre, M.A.; Slupsky, C.M.; Rucker, R.B. Dietary Pyrroloquinoline Quinone (PQQ) Alters Indicators of Inflammation and Mitochondrial-Related Metabolism in Human Subjects. J. Nutr. Biochem. 2013, 24, 2076–2084. [Google Scholar] [CrossRef]
- Smidt, C.R.; Unkefer, C.J.; Houck, D.R.; Rucker, R.B. Intestinal Absorption and Tissue Distribution of [14C]Pyrroloquinoline Quinone in Mice. Exp. Biol. Med. 1991, 197, 27–31. [Google Scholar] [CrossRef]
- Ikemoto, K.; Mohamad Ishak, N.S.; Akagawa, M. The Effects of Pyrroloquinoline Quinone Disodium Salt on Brain Function and Physiological Processes. J. Med. Investig. 2024, 71, 23–28. [Google Scholar] [CrossRef]
- Kumazawa, T.; Seno, H.; Urakami, T.; Matsumoto, T.; Suzuki, O. Trace Levels of Pyrroloquinoline Quinone in Human and Rat Samples Detected by Gas Chromatography/Mass Spectrometry. Biochim. Biophys. Acta (BBA)-Gen. Subj. 1992, 1156, 62–66. [Google Scholar] [CrossRef]
- Stites, T.E.; Mitchell, A.E.; Rucker, R.B. Physiological Importance of Quinoenzymes and the O-Quinone Family of Cofactors. J. Nutr. 2000, 130, 719–727. [Google Scholar] [CrossRef] [PubMed]
- Paz, M.A.; Flückiger, R.; Gallop, P.M. Comment: Redox-cycling Is a Property of PQQ but Not of Ascorbate. FEBS Lett. 1990, 264, 283–284. [Google Scholar] [CrossRef] [PubMed]
- Fluckiger, R.; Paz, M.; Mah, J.; Bishop, A.; Gallop, P.M. Characterization of the Glycine-Dependent Redox-Cycling Activity in Animal Fluids and Tissues Using Specific Inhibitors and Activators: Evidence for Presence of PQQ. Biochem. Biophys. Res. Commun. 1993, 196, 61–68. [Google Scholar] [CrossRef]
- Akagawa, M.; Minematsu, K.; Shibata, T.; Kondo, T.; Ishii, T.; Uchida, K. Identification of Lactate Dehydrogenase as a Mammalian Pyrroloquinoline Quinone (PQQ)-Binding Protein. Sci. Rep. 2016, 6, 26723. [Google Scholar] [CrossRef]
- Ouchi, A.; Ikemoto, K.; Nakano, M.; Nagaoka, S.; Mukai, K. Kinetic Study of Aroxyl Radical Scavenging and α-Tocopheroxyl Regeneration Rates of Pyrroloquinolinequinol (PQQH2, a Reduced Form of Pyrroloquinolinequinone) in Dimethyl Sulfoxide Solution: Finding of Synergistic Effect on the Reaction Rate Due to the Coexistence of α-Tocopherol and PQQH2. J. Agric. Food Chem. 2013, 61, 11048–11060. [Google Scholar] [CrossRef]
- Stites, T.; Storms, D.; Bauerly, K.; Mah, J.; Harris, C.; Fascetti, A.; Rogers, Q.; Tchaparian, E.; Satre, M.; Rucker, R.B. Pyrroloquinoline Quinone Modulates Mitochondrial Quantity and Function in Mice. J. Nutr. 2006, 136, 390–396. [Google Scholar] [CrossRef]
- Chowanadisai, W.; Bauerly, K.A.; Tchaparian, E.; Wong, A.; Cortopassi, G.A.; Rucker, R.B. Pyrroloquinoline Quinone Stimulates Mitochondrial Biogenesis through CAMP Response Element-Binding Protein Phosphorylation and Increased PGC-1α Expression. J. Biol. Chem. 2010, 285, 142–152. [Google Scholar] [CrossRef] [PubMed]
- Hwang, P.S.; Machek, S.B.; Cardaci, T.D.; Wilburn, D.T.; Kim, C.S.; Suezaki, E.S.; Willoughby, D.S. Effects of Pyrroloquinoline Quinone (PQQ) Supplementation on Aerobic Exercise Performance and Indices of Mitochondrial Biogenesis in Untrained Men. J. Am. Coll. Nutr. 2020, 39, 547–556. [Google Scholar] [CrossRef]
- Tchaparian, E.; Marshal, L.; Cutler, G.; Bauerly, K.; Chowanadisai, W.; Satre, M.; Harris, C.; Rucker, R.B. Identification of Transcriptional Networks Responding to Pyrroloquinoline Quinone Dietary Supplementation and Their Influence on Thioredoxin Expression, and the JAK/STAT and MAPK Pathways. Biochem. J. 2010, 429, 515–526. [Google Scholar] [CrossRef]
- Kumar, N.; Kar, A. Pyrroloquinoline Quinone (PQQ) Has Potential to Ameliorate Streptozotocin-Induced Diabetes Mellitus and Oxidative Stress in Mice: A Histopathological and Biochemical Study. Chem. Biol. Interact. 2015, 240, 278–290. [Google Scholar] [CrossRef]
- European Food Safety Authority (EFSA). Dietary Reference Values for Nutrients Summary Report. EFSA Support. Publ. 2017, 14, e15121. [Google Scholar] [CrossRef]
- Nair, A.; Jacob, S. A Simple Practice Guide for Dose Conversion between Animals and Human. J. Basic Clin. Pharm. 2016, 7, 27. [Google Scholar] [CrossRef] [PubMed]
- Shaikh, S.R.; Beck, M.A.; Alwarawrah, Y.; MacIver, N.J. Emerging Mechanisms of Obesity-Associated Immune Dysfunction. Nat. Rev. Endocrinol. 2023, 20, 136–148. [Google Scholar] [CrossRef]
- Blüher, M. Obesity: Global Epidemiology and Pathogenesis. Nat. Rev. Endocrinol. 2019, 15, 288–298. [Google Scholar] [CrossRef]
- Guilherme, A.; Virbasius, J.V.; Puri, V.; Czech, M.P. Adipocyte Dysfunctions Linking Obesity to Insulin Resistance and Type 2 Diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9, 367–377. [Google Scholar] [CrossRef]
- Kershaw, E.E.; Flier, J.S. Adipose Tissue as an Endocrine Organ. J. Clin. Endocrinol. Metab. 2004, 89, 2548–2556. [Google Scholar] [CrossRef] [PubMed]
- Guh, D.P.; Zhang, W.; Bansback, N.; Amarsi, Z.; Birmingham, C.L.; Anis, A.H. The Incidence of Co-Morbidities Related to Obesity and Overweight: A Systematic Review and Meta-Analysis. BMC Public Health 2009, 9, 88. [Google Scholar] [CrossRef]
- Mohamad Ishak, N.S.; Ikemoto, K.; Kikuchi, M.; Ogawa, M.; Akutagawa, K.; Akagawa, M. Pyrroloquinoline Quinone Attenuates Fat Accumulation in Obese Mice Fed with a High-Fat Diet, Daphnia Magna Supplied with a High Amount of Food, and 3T3-L1 Adipocytes. ACS Food Sci. Technol. 2021, 1, 1979–1989. [Google Scholar] [CrossRef]
- Zhang, J.; Powell, C.; Meruvu, S.; Sonkar, R.; Choudhury, M. Pyrroloquinoline Quinone Attenuated Benzyl Butyl Phthalate Induced Metabolic Aberration and a Hepatic Metabolomic Analysis. Biochem. Pharmacol. 2022, 197, 114883. [Google Scholar] [CrossRef]
- Devasani, K.; Kaul, R.; Majumdar, A. Supplementation of Pyrroloquinoline Quinone with Atorvastatin Augments Mitochondrial Biogenesis and Attenuates Low Grade Inflammation in Obese Rats. Eur. J. Pharmacol. 2020, 881, 173273. [Google Scholar] [CrossRef]
- Li, Y.; Xu, S.; Mihaylova, M.M.; Zheng, B.; Hou, X.; Jiang, B.; Park, O.; Luo, Z.; Lefai, E.; Shyy, J.Y.-J.; et al. AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice. Cell Metab. 2011, 13, 376–388. [Google Scholar] [CrossRef]
- Wu, Z.; Puigserver, P.; Andersson, U.; Zhang, C.; Adelmant, G.; Mootha, V.; Troy, A.; Cinti, S.; Lowell, B.; Scarpulla, R.C.; et al. Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1. Cell 1999, 98, 115–124. [Google Scholar] [CrossRef] [PubMed]
- Nakano, M.; Kawasaki, Y.; Suzuki, N.; Takara, T. Effects of Pyrroloquinoline Quinone Disodium Salt Intake on the Serum Cholesterol Levels of Healthy Japanese Adults. J. Nutr. Sci. Vitaminol. 2015, 61, 233–240. [Google Scholar] [CrossRef] [PubMed]
- Mansouri, A.; Gattolliat, C.-H.; Asselah, T. Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases. Gastroenterology 2018, 155, 629–647. [Google Scholar] [CrossRef] [PubMed]
- Paoli, A.; Cerullo, G. Investigating the Link between Ketogenic Diet, NAFLD, Mitochondria, and Oxidative Stress: A Narrative Review. Antioxidants 2023, 12, 1065. [Google Scholar] [CrossRef] [PubMed]
- Saltiel, A.R.; Olefsky, J.M. Inflammatory Mechanisms Linking Obesity and Metabolic Disease. J. Clin. Investig. 2017, 127, 1–4. [Google Scholar] [CrossRef]
- Bauerly, K.; Harris, C.; Chowanadisai, W.; Graham, J.; Havel, P.J.; Tchaparian, E.; Satre, M.; Karliner, J.S.; Rucker, R.B. Altering Pyrroloquinoline Quinone Nutritional Status Modulates Mitochondrial, Lipid, and Energy Metabolism in Rats. PLoS ONE 2011, 6, e21779. [Google Scholar] [CrossRef]
- Han, G.; Cai, W.; Zhang, Y.; Zhou, S.; He, B.; Li, H. Protective Effect of Pyrroloquinoline Quinone on TNF-α-Induced Mitochondrial Injury in Chondrocytes. Curr. Med. Sci. 2021, 41, 100–107. [Google Scholar] [CrossRef]
- Xu, X.; Chen, C.; Lu, W.-J.; Su, Y.-L.; Shi, J.-Y.; Liu, Y.-C.; Wang, L.; Xiao, C.-X.; Wu, X.; Lu, Q. Pyrroloquinoline Quinone Can Prevent Chronic Heart Failure by Regulating Mitochondrial Function. Cardiovasc. Diagn. Ther. 2020, 10, 453–469. [Google Scholar] [CrossRef]
- Xin, P.; Xu, X.; Deng, C.; Liu, S.; Wang, Y.; Zhou, X.; Ma, H.; Wei, D.; Sun, S. The Role of JAK/STAT Signaling Pathway and Its Inhibitors in Diseases. Int. Immunopharmacol. 2020, 80, 106210. [Google Scholar] [CrossRef]
- Hwang, P.; Willoughby, D.S. Mechanisms Behind Pyrroloquinoline Quinone Supplementation on Skeletal Muscle Mitochondrial Biogenesis: Possible Synergistic Effects with Exercise. J. Am. Coll. Nutr. 2018, 37, 738–748. [Google Scholar] [CrossRef]
- Sharples, A.P.; Hughes, D.C.; Deane, C.S.; Saini, A.; Selman, C.; Stewart, C.E. Longevity and Skeletal Muscle Mass: The Role of IGF Signalling, the Sirtuins, Dietary Restriction and Protein Intake. Aging Cell 2015, 14, 511–523. [Google Scholar] [CrossRef] [PubMed]
- Liu, L.; Zhang, Y.; Liu, T.; Ke, C.; Huang, J.; Fu, Y.; Lin, Z.; Chen, F.; Wu, X.; Chen, Q. Pyrroloquinoline Quinone Protects against Exercise-induced Fatigue and Oxidative Damage via Improving Mitochondrial Function in Mice. FASEB J. 2021, 35, e21394. [Google Scholar] [CrossRef]
- Kobayashi, A.; Kang, M.-I.; Okawa, H.; Ohtsuji, M.; Zenke, Y.; Chiba, T.; Igarashi, K.; Yamamoto, M. Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2. Mol. Cell Biol. 2004, 24, 7130–7139. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; Han, N.; Zhao, K.; Li, Y.; Chi, Y.; Wang, B. Protective Effects of Pyrroloquinoline Quinone against Oxidative Stress-Induced Cellular Senescence and Inflammation in Human Renal Tubular Epithelial Cells via Keap1/Nrf2 Signaling Pathway. Int. Immunopharmacol. 2019, 72, 445–453. [Google Scholar] [CrossRef] [PubMed]
- Lin, X.; Yang, F.; Huang, J.; Jiang, S.; Tang, Y.; Li, J. Ameliorate Effect of Pyrroloquinoline Quinone against Cyclophosphamide-Induced Nephrotoxicity by Activating the Nrf2 Pathway and Inhibiting the NLRP3 Pathway. Life Sci. 2020, 256, 117901. [Google Scholar] [CrossRef]
- Kumar, A.A.; Kelly, D.P.; Chirinos, J.A. Mitochondrial Dysfunction in Heart Failure with Preserved Ejection Fraction. Circulation 2019, 139, 1435–1450. [Google Scholar] [CrossRef]
- Tao, R.; Karliner, J.S.; Simonis, U.; Zheng, J.; Zhang, J.; Honbo, N.; Alano, C.C. Pyrroloquinoline Quinone Preserves Mitochondrial Function and Prevents Oxidative Injury in Adult Rat Cardiac Myocytes. Biochem. Biophys. Res. Commun. 2007, 363, 257–262. [Google Scholar] [CrossRef]
- Zhu, B.; Zhou, H.; Teerlink, J.R.; Karliner, J.S. Pyrroloquinoline Quinone (PQQ) Decreases Myocardial Infarct Size and Improves Cardiac Function in Rat Models of Ischemia and Ischemia/Reperfusion. Cardiovasc. Drugs Ther. 2004, 18, 421–431. [Google Scholar] [CrossRef]
- Zhang, Q.; Zhou, J.; Shen, M.; Xu, H.; Yu, S.; Cheng, Q.; Ding, F. Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy. Molecules 2020, 25, 4359. [Google Scholar] [CrossRef]
- Li, R.; Xia, J.; Zhang, X.; Gathirua-mwangi, W.G.G.J.; Li, Y.; Mckenzie, S.; Song, Y. Associations of Muscle Mass and Strength with All-Cause Mortality among US Older Adults. Med. Sci. Sports Exerc. 2018, 50, 458–467. [Google Scholar] [CrossRef]
- Camargo Pereira, C.; Pagotto, V.; de Oliveira, C.; Silveira, E.A. Low Muscle Mass and Mortality Risk Later in Life: A 10-Year Follow-up Study. PLoS ONE 2022, 17, e0271579. [Google Scholar] [CrossRef] [PubMed]
- Joanisse, S.; Lim, C.; McKendry, J.; Mcleod, J.C.; Stokes, T.; Phillips, S.M. Recent Advances in Understanding Resistance Exercise Training-Induced Skeletal Muscle Hypertrophy in Humans. F1000Research 2020, 9, 141. [Google Scholar] [CrossRef] [PubMed]
- Mitchell, W.K.; Wilkinson, D.J.; Phillips, B.E.; Lund, J.N.; Smith, K.; Atherton, P.J. Human Skeletal Muscle Protein Metabolism Responses to Amino Acid Nutrition. Adv. Nutr. 2016, 7, 828S–838S. [Google Scholar] [CrossRef]
- Paoli, A.; Cerullo, G.; Bianco, A.; Neri, M.; Gennaro, F.; Charrier, D.; Moro, T. Not Only Protein: Dietary Supplements to Optimize the Skeletal Muscle Growth Response to Resistance Training: The Current State of Knowledge. J. Hum. Kinet. 2024, 91, 225–244. [Google Scholar] [CrossRef]
- Tuttle, C.S.L.; Thang, L.A.N.; Maier, A.B. Markers of Inflammation and Their Association with Muscle Strength and Mass: A Systematic Review and Meta-Analysis. Ageing Res. Rev. 2020, 64, 101185. [Google Scholar] [CrossRef]
- Kawai, T.; Autieri, M.V.; Scalia, R. Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity. Am. J. Physiol.-Cell Physiol. 2021, 320, C375–C391. [Google Scholar] [CrossRef]
- Ma, W.; Zhang, R.; Huang, Z.; Zhang, Q.; Xie, X.; Yang, X.; Zhang, Q.; Liu, H.; Ding, F.; Zhu, J.; et al. PQQ Ameliorates Skeletal Muscle Atrophy, Mitophagy and Fiber Type Transition Induced by Denervation via Inhibition of the Inflammatory Signaling Pathways. Ann. Transl. Med. 2019, 7, 440. [Google Scholar] [CrossRef] [PubMed]
- Ji, L.L.; Yeo, D.; Kang, C.; Zhang, T. The Role of Mitochondria in Redox Signaling of Muscle Homeostasis. J. Sport Health Sci. 2020, 9, 386–393. [Google Scholar] [CrossRef]
- Bouviere, J.; Fortunato, R.S.; Dupuy, C.; Werneck-de-Castro, J.P.; Carvalho, D.P.; Louzada, R.A. Exercise-Stimulated ROS Sensitive Signaling Pathways in Skeletal Muscle. Antioxidants 2021, 10, 537. [Google Scholar] [CrossRef] [PubMed]
- Winbanks, C.E.; Murphy, K.T.; Bernardo, B.C.; Qian, H.; Liu, Y.; Sepulveda, P.V.; Beyer, C.; Hagg, A.; Thomson, R.E.; Chen, J.L.; et al. Smad7 Gene Delivery Prevents Muscle Wasting Associated with Cancer Cachexia in Mice. Sci. Transl. Med. 2016, 8, 348ra98. [Google Scholar] [CrossRef] [PubMed]
- Sandri, M.; Lin, J.; Handschin, C.; Yang, W.; Arany, Z.P.; Lecker, S.H.; Goldberg, A.L.; Spiegelman, B.M. PGC-1α Protects Skeletal Muscle from Atrophy by Suppressing FoxO3 Action and Atrophy-Specific Gene Transcription. Proc. Natl. Acad. Sci. USA 2006, 103, 16260–16265. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Charrier, D.; Cerullo, G.; Carpenito, R.; Vindigni, V.; Bassetto, F.; Simoni, L.; Moro, T.; Paoli, A. Metabolic and Biochemical Effects of Pyrroloquinoline Quinone (PQQ) on Inflammation and Mitochondrial Dysfunction: Potential Health Benefits in Obesity and Future Perspectives. Antioxidants 2024, 13, 1027. https://doi.org/10.3390/antiox13091027
Charrier D, Cerullo G, Carpenito R, Vindigni V, Bassetto F, Simoni L, Moro T, Paoli A. Metabolic and Biochemical Effects of Pyrroloquinoline Quinone (PQQ) on Inflammation and Mitochondrial Dysfunction: Potential Health Benefits in Obesity and Future Perspectives. Antioxidants. 2024; 13(9):1027. https://doi.org/10.3390/antiox13091027
Chicago/Turabian StyleCharrier, Davide, Giuseppe Cerullo, Roberta Carpenito, Vincenzo Vindigni, Franco Bassetto, Luca Simoni, Tatiana Moro, and Antonio Paoli. 2024. "Metabolic and Biochemical Effects of Pyrroloquinoline Quinone (PQQ) on Inflammation and Mitochondrial Dysfunction: Potential Health Benefits in Obesity and Future Perspectives" Antioxidants 13, no. 9: 1027. https://doi.org/10.3390/antiox13091027